Live Breaking News & Updates on போது ஹாங் காங்|Page 3
Stay updated with breaking news from போது ஹாங் காங். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Posted on May 27th, 2021 Courtesy Adaderana Vaccines from China’s Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literature. The two inactivated vaccines developed by Sinopharm’s vaccine-making unit China National Biotec Group Co. prevented symptomatic infections by 72.8% and 78.1%, largely in-line with what the state-owned drugmaker previously announced. The findings were reported in the May 26 Journal of the American Medical Association (JAMA). Chinese shots, including those from Sinopharm and Sinovac Biotech Ltd., another Beijing-based vaccine maker, have formed the backbone of the vaccine rollout in developing countries ranging from Hungary and Serbia to Seychelles and Peru. The immunizations have come under scrutiny and their manufacturers have been criticized ....
China’s Sinopharm Publishes Long-Awaited Vaccine Trial Findings The two inactivated vaccines developed by Sinopharm’s vaccine-making unit prevented symptomatic infections by 72.8% and 78.1%, largely in-line with what the state-owned drugmaker previously announced. Photo: VCG (Bloomberg) Vaccines from China’s Sinopharm successfully contained Covid-19, according to a study published in a prestigious U.S. medical journal, the first time detailed findings from a late-stage trial of a Chinese shot have appeared in the scientific literature. The two inactivated vaccines developed by Sinopharm’s vaccine-making unit China National Biotec Group Co. Ltd. prevented symptomatic infections by 72.8% and 78.1%, largely in-line with what the state-owned drugmaker previously announced. The findings were reported in the May 26 Journal of the American Medical Association (JAMA). ....
Advertisement While Hong Kong offers free vaccinations to anyone over the age of 16, more than 13,000 refugees and asylum seekers have so far been excluded from the inoculation drive due to their lack of residency status – a decision that has sparked widespread criticism. Despite the availability of jabs, the city’s vaccine take-up has been slow. Like others in Asia, the city’s early success in containing COVID-19 made the public less fearful of the virus, and more likely to choose to wait before getting the shot. The rollout has also been hampered by a growing public mistrust in authorities. Yet as unused vaccines pile up, officials still maintain that shots will not be offered to refugees or asylum seekers at this stage. ....
Merck hebt die Prognose an, Siemens Energy enttäuscht und T-Mobile US akquiriert erfolgreich finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.